USD 0.12
(-33.33%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 2.72 Million USD | 217.11% |
2022 | -1.03 Million USD | -511.38% |
2021 | 625.64 Thousand USD | -140.28% |
2020 | 683.17 Thousand USD | -52.62% |
2019 | 1.44 Million USD | 69.2% |
2018 | 841.73 Thousand USD | -0.64% |
2017 | 845.3 Thousand USD | -36.6% |
2016 | 1.33 Million USD | 149.61% |
2015 | -2.69 Million USD | -125.0% |
2014 | -1.19 Million USD | -47.87% |
2013 | -59.53 Thousand USD | 41.0% |
2012 | -1.37 Million USD | 0.0% |
2008 | -15.03 Million USD | 82.75% |
2007 | -7.11 Million USD | -1132.89% |
2006 | -855.15 Thousand USD | -125.38% |
2005 | 1.92 Million USD | 36.68% |
2004 | 1.44 Million USD | 1354.63% |
2003 | -120.9 Thousand USD | 97.68% |
2002 | -5.33 Million USD | 25.95% |
2001 | -6.74 Million USD | -25.55% |
2000 | -5.32 Million USD | 68.95% |
1999 | -3.82 Million USD | -5845.23% |
1998 | -6.3 Million USD | 107.14% |
1997 | -5.27 Million USD | -940.0% |
1996 | 1.6 Million USD | 155.56% |
1995 | -800 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 FY | - USD | 217.11% |
2023 Q1 | - USD | 100.0% |
2022 Q4 | -1.73 Million USD | -1469.8% |
2022 FY | - USD | -511.38% |
2022 Q2 | 91.61 Thousand USD | 1.8% |
2022 Q1 | 89.99 Thousand USD | 336.88% |
2022 Q3 | -110.56 Thousand USD | -220.69% |
2021 Q1 | 99.47 Thousand USD | 119415.8% |
2021 FY | - USD | -140.28% |
2021 Q2 | -161.58 Thousand USD | -262.44% |
2021 Q3 | -171.71 Thousand USD | -6.27% |
2021 Q4 | -37.99 Thousand USD | 77.88% |
2020 Q3 | -26.09 Thousand USD | 26.68% |
2020 FY | - USD | -52.62% |
2020 Q4 | -83.37 USD | 99.68% |
2020 Q2 | -35.58 Thousand USD | -154.11% |
2020 Q1 | 65.76 Thousand USD | -38.45% |
2019 Q3 | 289.03 Thousand USD | 30.11% |
2019 Q1 | 355.62 Thousand USD | 68.14% |
2019 FY | - USD | 69.2% |
2019 Q4 | 106.85 Thousand USD | -63.03% |
2019 Q2 | 222.14 Thousand USD | -37.54% |
2018 Q3 | 265.29 Thousand USD | -19.24% |
2018 Q1 | 38.09 Thousand USD | -92.23% |
2018 Q4 | 211.5 Thousand USD | -20.28% |
2018 FY | - USD | -0.64% |
2018 Q2 | 328.48 Thousand USD | 762.29% |
2017 Q3 | 156.33 Thousand USD | -49.9% |
2017 Q1 | -112.53 Thousand USD | -141.19% |
2017 Q2 | 312.05 Thousand USD | 377.29% |
2017 Q4 | 490.14 Thousand USD | 213.53% |
2017 FY | - USD | -36.6% |
2016 Q1 | 196.81 Thousand USD | 223.9% |
2016 Q2 | 384.29 Thousand USD | 95.25% |
2016 Q4 | 273.2 Thousand USD | -43.31% |
2016 Q3 | 481.9 Thousand USD | 25.4% |
2016 FY | - USD | 149.61% |
2015 Q1 | -973.56 Thousand USD | -417.41% |
2015 Q3 | -213.84 Thousand USD | 84.12% |
2015 Q4 | -158.84 Thousand USD | 25.72% |
2015 FY | - USD | -125.0% |
2015 Q2 | -1.34 Million USD | -38.33% |
2014 Q3 | -378.95 Thousand USD | -5.28% |
2014 FY | - USD | -47.87% |
2014 Q1 | -272.73 Thousand USD | -228.89% |
2014 Q2 | -359.97 Thousand USD | -31.99% |
2014 Q4 | -188.16 Thousand USD | 50.35% |
2013 Q1 | -367.19 USD | -519.15% |
2013 FY | - USD | 41.0% |
2013 Q3 | 145.7 Thousand USD | 118.53% |
2013 Q4 | 211.59 Thousand USD | 45.23% |
2013 Q2 | -786.31 Thousand USD | -214045.38% |
2012 Q4 | -59.31 USD | 0.0% |
2012 FY | - USD | 0.0% |
2009 Q1 | -28.26 Thousand USD | -100.94% |
2008 Q3 | -1.29 Million USD | 43.53% |
2008 FY | - USD | 82.75% |
2008 Q4 | 3 Million USD | 332.34% |
2008 Q2 | -2.29 Million USD | -34.69% |
2008 Q1 | -1.7 Million USD | 0.25% |
2007 Q1 | -1.21 Million USD | -190.35% |
2007 Q3 | -1.84 Million USD | -28.11% |
2007 FY | - USD | -1132.89% |
2007 Q4 | -1.7 Million USD | 7.37% |
2007 Q2 | -1.43 Million USD | -17.97% |
2006 Q3 | -344.33 Thousand USD | 9.83% |
2006 FY | - USD | -125.38% |
2006 Q4 | -419.5 Thousand USD | -21.83% |
2006 Q2 | -381.88 Thousand USD | -209.81% |
2006 Q1 | 347.78 Thousand USD | 28.2% |
2005 Q3 | 552.74 Thousand USD | 31.09% |
2005 Q4 | 271.27 Thousand USD | -50.92% |
2005 Q2 | 421.64 Thousand USD | -37.56% |
2005 Q1 | 675.28 Thousand USD | 15.58% |
2005 FY | - USD | 36.68% |
2004 FY | - USD | 1354.63% |
2004 Q4 | 584.24 Thousand USD | 10.78% |
2004 Q3 | 527.39 Thousand USD | 125.41% |
2004 Q1 | 96.26 Thousand USD | 245.1% |
2004 Q2 | 233.97 Thousand USD | 143.04% |
2003 Q4 | -72.42 Thousand USD | -144.94% |
2003 Q1 | -236.43 Thousand USD | 71.35% |
2003 FY | - USD | 97.68% |
2003 Q2 | 40.09 Thousand USD | 116.98% |
2003 Q3 | 147.85 Thousand USD | 266.59% |
2002 Q4 | -827.92 Thousand USD | 27.54% |
2002 FY | - USD | 25.95% |
2002 Q1 | -1.54 Million USD | 16.96% |
2002 Q2 | -1.46 Million USD | 5.45% |
2002 Q3 | -1.5 Million USD | 21.81% |
2001 FY | - USD | -25.55% |
2001 Q4 | -1.85 Million USD | -4.39% |
2001 Q3 | -1.78 Million USD | -11.36% |
2001 Q2 | -1.59 Million USD | -8.42% |
2001 Q1 | -1.49 Million USD | -2.58% |
2000 Q1 | -1.11 Million USD | 53.97% |
2000 FY | - USD | 68.95% |
2000 Q4 | -1.43 Million USD | -5.32% |
2000 Q3 | -1.35 Million USD | 4.14% |
2000 Q2 | -1.42 Million USD | -27.13% |
1999 Q4 | -1.12 Million USD | -143.57% |
1999 Q2 | -800 Thousand USD | -991.67% |
1999 Q1 | -987.05 Thousand USD | -100.0% |
1999 Q3 | -1 Million USD | 92.37% |
1999 FY | - USD | -5845.23% |
1998 FY | - USD | 107.14% |
1998 Q4 | -400 Thousand USD | -113.33% |
1998 Q3 | -1.4 Million USD | 304.55% |
1998 Q2 | -2.1 Million USD | -57.14% |
1998 Q1 | -2.3 Million USD | -450.0% |
1997 Q3 | -1.6 Million USD | -83.33% |
1997 FY | - USD | -940.0% |
1997 Q2 | -700 Thousand USD | -20.0% |
1997 Q1 | -600 Thousand USD | -400.0% |
1997 Q4 | -2.1 Million USD | 118.18% |
1996 Q4 | 300 Thousand USD | -300.0% |
1996 Q3 | 600 Thousand USD | -75.0% |
1996 Q2 | 500 Thousand USD | 100.0% |
1996 Q1 | 200 Thousand USD | 102.6% |
1996 FY | - USD | 155.56% |
1995 Q1 | 1.9 Million USD | 0.0% |
1995 Q2 | 2.1 Million USD | 10.53% |
1995 Q3 | 2.8 Million USD | 33.33% |
1995 FY | - USD | 0.0% |
1995 Q4 | -7.7 Million USD | -375.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Achiko AG | -8.32 Million USD | 132.773% |
Accelera Innovations, Inc | - USD | -Infinity% |
Aspyra Inc. | -2.84 Million USD | 195.861% |
Cannabis Sativa, Inc. | -1.11 Million USD | 344.816% |
CompuMed, Inc. | 690.19 Thousand USD | -295.333% |
CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 98.718% |
Cogstate Limited | 9.89 Million USD | 72.415% |
CareView Communications, Inc. | -210.04 Thousand USD | 1399.058% |
Craneware plc | 54.26 Million USD | 94.971% |
Caduceus Software Systems Corp. | -12.29 Million USD | 122.197% |
Certive Solutions Inc. | -704.66 Thousand USD | 487.213% |
Drug Free Solution, Inc. | -1.39 Million USD | 295.606% |
Strainsforpains, Inc. | -65.61 Thousand USD | 4258.747% |
Healixa Inc. | -6.32 Million USD | 143.171% |
Easy Technologies Inc. | - USD | -Infinity% |
eWellness Healthcare Corporation | - USD | -Infinity% |
Founders Bay Holdings | 10.16 Million USD | 73.167% |
Health Discovery Corporation | - USD | -Infinity% |
Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 741.276% |
H-Source Holdings Ltd. | - USD | -Infinity% |
InterCare DX, Inc. | - USD | -Infinity% |
IQ-AI Limited | -370.35 Thousand USD | 836.744% |
Cannabiz Mobile, Inc. | -750.00 USD | 363907.2% |
Mednow Inc. | -28.12 Million USD | 109.702% |
Galileo Life Sciences, Inc. | -270.72 Thousand USD | 1107.877% |
MediXall Group, Inc. | -6.52 Million USD | 141.826% |
Mitesco, Inc. | -11.96 Million USD | 122.808% |
MobileSmith, Inc. | -13.83 Million USD | 119.719% |
NantHealth, Inc. | -38.53 Million USD | 107.081% |
Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 260.692% |
OneLife Technologies Corp. | - USD | -Infinity% |
ORHub, Inc. | -12.08 Million USD | 122.575% |
Patient Access Solutions, Inc. | -12.09 Million USD | 122.553% |
Pharma-Bio Serv, Inc. | 1.31 Million USD | -108.012% |
PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | -3551.216% |
Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | 22494.567% |
Renalytix Plc | -28.52 Million USD | 109.567% |
Revium Recovery Inc. | -678 Thousand USD | 502.442% |
RYAH Group, Inc. | - USD | -Infinity% |
Carepay Inc. | -369.00 USD | 739545.528% |
Vaso Corporation | 4.19 Million USD | 34.957% |
Vynleads, Inc. | -235.72 Thousand USD | 1257.511% |